Abstract
This study addresses the effects of micafungin, caspofungin, and anidulafungin against Candida albicans biofilms developed in a subcutaneous catheter rat model system. Doses of 5, 10, and 30 mg/kg (of body weight)/day (the last only for micafungin) were given intravenously for 5, 7, and 10 days. All three echinocandins caused a significant reduction of the Candida cell numbers on the implanted catheters and are thus promising for the treatment of biofilm-related infections.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antifungal Agents / pharmacology*
-
Biofilms / drug effects*
-
Biofilms / growth & development
-
Candida albicans / drug effects*
-
Candida albicans / growth & development
-
Candidiasis / drug therapy*
-
Candidiasis / microbiology
-
Catheters, Indwelling / microbiology
-
Dermatologic Surgical Procedures
-
Echinocandins / pharmacology*
-
Female
-
Injections, Intravenous
-
Rats
-
Rats, Sprague-Dawley
-
Skin / drug effects*
-
Skin / microbiology
Substances
-
Antifungal Agents
-
Echinocandins